Concepedia
Statistics
Publications
16
Citations
546
H-Index
13
Active since
2015
Affiliations
Central Drug Research Institute(Current)
Indian Institute of Toxicology Research
Academy of Scientific and Innovative Research
Jayant Dewangan is an author at Central Drug Research Institute specializing in pharmacology, oncology, and molecular oncology.
Publications per year
2015–2022
Salinomycin inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vitro and in vivo
Jayant Dewangan, Sonal Srivastava, Sakshi Mishra et al. · Biochemical Pharmacology · 2019 · 67 citations
Medicine, Oncology, Pharmacology +14
Novel combination of salinomycin and resveratrol synergistically enhances the anti-proliferative and pro-apoptotic effects on human breast cancer cells
Jayant Dewangan, Divya Tandon, Sonal Srivastava et al. · APOPTOSIS · 2017 · 66 citations
Medicine, Oncology, Pharmacology +12
Isoniazid prevents Nrf2 translocation by inhibiting ERK1 phosphorylation and induces oxidative stress and apoptosis
Ajeet Kumar Verma, Arti Yadav, Jayant Dewangan et al. · Redox Biology · 2015 · 51 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
Piperine and Celecoxib synergistically inhibit colon cancer cell proliferation via modulating Wnt/β-catenin signaling pathway
Sonal Srivastava, Jayant Dewangan, Sakshi Mishra et al. · Phytomedicine · 2021 · 46 citations
Medicine, Oncology, Pharmacology +11
Click Biotinylation of PLGA Template for Biotin Receptor Oriented Delivery of Doxorubicin Hydrochloride in 4T1 Cell-Induced Breast Cancer
Yuvraj Singh, K. K. Durga Rao Viswanadham, Arun Kumar Jajoriya et al. · Molecular Pharmaceutics · 2017 · 45 citations
Pharmacy, Pharmaceutics, Pharmacology +17
1–5 of 16